Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep-Oct;23(5):611-629.
doi: 10.1002/pst.2376. Epub 2024 Mar 4.

Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data

Affiliations

Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data

Carl-Fredrik Burman et al. Pharm Stat. 2024 Sep-Oct.

Abstract

Recent years have seen an increasing interest in incorporating external control data for designing and evaluating randomized clinical trials (RCT). This may decrease costs and shorten inclusion times by reducing sample sizes. For small populations, with limited recruitment, this can be especially important. Bayesian dynamic borrowing (BDB) has been a popular choice as it claims to protect against potential prior data conflict. Digital twins (DT) has recently been proposed as another method to utilize historical data. DT, also known as PROCOVA™, is based on constructing a prognostic score from historical control data, typically using machine learning. This score is included in a pre-specified ANCOVA as the primary analysis of the RCT. The promise of this idea is power increase while guaranteeing strong type 1 error control. In this paper, we apply analytic derivations and simulations to analyze and discuss examples of these two approaches. We conclude that BDB and DT, although similar in scope, have fundamental differences which need be considered in the specific application. The inflation of the type 1 error is a serious issue for BDB, while more evidence is needed of a tangible value of DT for real RCTs.

Keywords: PROCOVA™; clinical trials; machine learning; prognostic score; robust mixture prior.

PubMed Disclaimer

References

REFERENCES

    1. Lewis C, Sarkar S, Zhu J, Carlin B. Borrowing from historical control data in cancer drug development: a cautionary tale and practical guidelines. Stat Biopharm Res. 2019;11:67‐78. doi:10.1080/19466315.2018.1497533
    1. US Food and Drug Administration (FDA). Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials. 2010.
    1. European Medicines Agency (EMA). Qualification opinion for Prognostic Covariate Adjustment (PROCOVA™). 2022.
    1. Zhang L, Wang Z, Wang L, Cui L, Sokolove J, Chan I. A simple approach to incorporating historical control data in clinical trial design and analysis. Stat Biosci. 2022;14:216‐236. doi:10.1007/s12561‐022‐09342‐w
    1. Pocock S. The combination of randomized and historical controls in clinical trials. J Chronic Dis. 1976;29:175‐188.

LinkOut - more resources